SALIF: Supplemental Anterior Lumbar Interbody Fusion (ALIF) in Spinal Deformity
Study Details
Study Description
Brief Summary
Within the last decade there has been an increase in the number of surgical procedures for deformities of the spine. This is caused by the increase in the elderly population, improved surgical techniques and an increased number of patients who have undergone previous surgical treatment for degenerative conditions of the spine. Surgical treatment of spinal deformities bears a revision rate between 15 and 30% depending on definition, and one of the primary reasons for revision surgery is implant loosening in the lumbosacral region.
The hypothesis of the study is that a procedure resulting in anterior fusion of the lumbar spine in addition to the usual posterior instrumentation can reduce the revision rate with 50%.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Anterior lumbar interbody fusion Anterior lumbar interbody fusion using a tantalum cage. Cage will be inserted through a left sided retroperitoneal approach. |
Device: Tantalum cage from Zimmer
A tantalum cage will be inserted through a left sided retroperitoneal approach
Other Names:
|
Active Comparator: Posterior instrumentation alone Posterior pedicle screw instrumentation |
Device: Tantalum cage from Zimmer
A tantalum cage will be inserted through a left sided retroperitoneal approach
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Revision [12 months]
Surgical revision rate because of implant failure or pseudarthrosis within 12 months after primary procedure
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 years or more of age
-
planned posterior instrumented fusion from thoracic spine to sacrum and/or ilium
Exclusion Criteria:
-
malignancy
-
infection
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Spine Unit, Rigshospitalet, 9 Blegdamsvej | Copenhagen | Osterbro | Denmark | 2100 |
Sponsors and Collaborators
- Rigshospitalet, Denmark
Investigators
- Principal Investigator: Benny Dahl, MD, University of Copenhagen, Rigshospitalet
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- H-2-2012-003